Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
Chubb
Healthtrust
Chinese Patent Office
UBS
Merck
Julphar
Argus Health
Farmers Insurance

Generated: May 25, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 073457

« Back to Dashboard

NDA 073457 describes ATENOLOL, which is a drug marketed by Able, Alvogen Malta, Apothecon, Aurobindo Pharma, Dava Pharms Inc, Ipca Labs Ltd, Mylan, Northstar Hlthcare, Nostrum Labs, Pliva, Sandoz, SCS, Sun Pharm Inds Inc, Sun Pharm Industries, Teva, Teva Pharms, Unique Pharm Labs, Watson Labs, Watson Labs Teva, and Zydus Pharms Usa, and is included in forty NDAs. It is available from fifty-eight suppliers. Additional details are available on the ATENOLOL profile page.

The generic ingredient in ATENOLOL is atenolol; chlorthalidone. There are thirty-three drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the atenolol; chlorthalidone profile page.
Summary for 073457
Tradename:ATENOLOL
Applicant:Mylan
Ingredient:atenolol
Patents:0
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 073457
Mechanism of ActionAdrenergic beta-Antagonists
Suppliers and Packaging for NDA: 073457
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ATENOLOL atenolol TABLET;ORAL 073457 ANDA Mylan Pharmaceuticals Inc. 0378-0218 N 0378-0218-01
ATENOLOL atenolol TABLET;ORAL 073457 ANDA Mylan Pharmaceuticals Inc. 0378-0218 N 0378-0218-10

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength100MG
Approval Date:Jan 24, 1992TE:ABRLD:No

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength25MG
Approval Date:Apr 26, 1999TE:ABRLD:No

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength50MG
Approval Date:Jan 24, 1992TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
QuintilesIMS
Accenture
Medtronic
Citi
Harvard Business School
UBS
Merck
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.